Waddell & Associates’s Synovus SNV Stock Holding History

Waddell & Associates’s Portfolio SNV Stock Details SNV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-6,174	Closed	-$309K	–	485
2025 Q4	$309K	Buy	6,174 +1,910	+45%	+$91.8K	0.02%	271
2025 Q3	$209K	Buy	+4,264	New	+$219K	0.02%	301

Other funds holding SNV

WBWA

William B. Walkup & Associates Columbia, South Carolina $208M AUM 37.34% 1-Year Est. Return

Waddell & Associates's SNV Position: Q1 2026 in Review

Waddell & Associates sold out of Synovus (SNV) in Q1 2026, closing a stake of 6,174 shares — an estimated $309K sold.

Waddell & Associates first reported a position in SNV in Q3 2025 and held it in 2 quarters. The position peaked at $309K in Q4 2025. 1 fund tracked by Wall St. Rank holds SNV as of Q1 2026.

Waddell & Associates reported no remaining Synovus position as of Q1 2026 after selling out during the quarter.
Waddell & Associates sold 6,174 Synovus shares in Q1 2026, an estimated $309K.
Waddell & Associates first reported a position in Synovus in Q3 2025 and held it in 2 quarters.
Waddell & Associates's Synovus position peaked at $309K in Q4 2025.
1 fund tracked by Wall St. Rank held Synovus as of Q1 2026.

Based on Waddell & Associates's 13F filing for Q1 2026, filed 11 May 2026.